ALNY
Alnylam Pharmaceuticals Inc
224.50$
+0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 855.8% | 744.1% | 645.9% | 836.9% | 814.9% | 478.6% | 758.6% | 735.7% | 6.6% | 7.9% | 10.1% | 9.7% | 7.4% | 17.0% | 13.4% | 19.2% | 17.3% | 14.1% | 17.5% | 17.6% | 17.4% | 14.6% | 16.7% | 18.2% | 15.6% | 15.3% | 17.2% | 26.8% | 11.2% | 19.5% | 13.3% | 10.4% | 17.1% | 17.3% | 12.0% | 18.5% | 15.8% | 24.4% | 18.1% | 23.1% | 20.3% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.4% | 92.1% | 89.9% | 90.3% | 92.6% | 83.0% | 86.6% | 80.8% | 82.7% | 85.9% | 82.5% | 82.4% | 82.6% | 85.4% | 83.3% | 81.8% | 84.4% | 84.7% | 82.8% | 73.2% | 88.8% | 80.5% | 86.7% | 89.6% | 82.9% | 82.7% | 88.0% | 81.5% | 84.2% | 75.6% | 81.9% | 76.9% | 79.7% | |
| 717.4% | 601.6% | 458.8% | 568.8% | 557.2% | 310.5% | 442.3% | 460.0% | 6,763.9% | 623.0% | 387.8% | 366.5% | 229.5% | 280.8% | 170.5% | 149.1% | 128.5% | 103.0% | 104.7% | 82.8% | 103.7% | 88.6% | 79.7% | 91.5% | 92.8% | 78.2% | 72.2% | 78.0% | 33.7% | 61.9% | 52.8% | 44.6% | 54.1% | 50.6% | 44.6% | 41.8% | 28.7% | 33.9% | 31.3% | 32.0% | 31.4% | |
| 164.0% | 159.7% | 203.0% | 287.3% | 278.7% | 177.9% | 330.8% | 283.1% | 5,632.9% | 516.7% | 269.1% | 252.2% | 171.8% | 218.0% | 127.4% | 123.0% | 133.1% | 101.7% | 82.7% | 65.9% | 75.7% | 72.1% | 72.4% | 75.6% | 89.2% | 62.8% | 57.5% | 67.4% | 26.5% | 45.1% | 42.6% | 37.6% | 44.1% | 49.8% | 40.4% | 41.8% | 25.8% | 29.7% | 27.6% | 27.0% | 27.4% | |
| 881.5% | 761.4% | 661.8% | 856.2% | 835.8% | 488.4% | 773.1% | 743.2% | 12,396.8% | 1,139.8% | 657.0% | 618.7% | 401.3% | 498.8% | 297.9% | 272.1% | 261.6% | 204.7% | 187.4% | 148.7% | 179.4% | 160.7% | 152.1% | 167.1% | 182.1% | 141.0% | 129.7% | 145.3% | 60.3% | 106.9% | 95.4% | 82.2% | 98.2% | 100.4% | 85.0% | 83.6% | 54.7% | 63.6% | 58.9% | 59.0% | 58.9% | |
| -781.5% | -661.4% | -561.8% | -756.2% | -735.8% | -388.4% | -673.1% | -643.2% | -12,303.4% | -1,047.7% | -567.0% | -528.4% | -308.7% | -415.8% | -211.3% | -191.3% | -178.9% | -118.7% | -104.9% | -66.3% | -96.8% | -75.3% | -68.8% | -85.3% | -97.6% | -56.3% | -46.9% | -72.1% | 28.5% | -26.5% | -8.8% | 7.4% | -15.4% | -17.7% | 3.0% | -2.1% | 29.5% | 12.0% | 23.0% | 17.9% | 20.8% | |
| 16.1% | 12.6% | 11.2% | 16.2% | 19.3% | 11.2% | 26.5% | 20.4% | 328.5% | 50.3% | 22.6% | 19.6% | 14.1% | 10.1% | 5.5% | 26.2% | 22.8% | 17.4% | 18.3% | 15.2% | 21.5% | 14.2% | 19.9% | 19.0% | 15.5% | 8.9% | 9.1% | 9.4% | 4.1% | 7.1% | 7.1% | 5.0% | 6.9% | 6.6% | 6.5% | 5.2% | 3.6% | 11.8% | 5.9% | 6.4% | 6.8% | |
| -762.4% | -647.0% | -565.9% | -743.3% | -719.1% | -375.0% | -645.1% | -546.6% | -11,833.6% | -1,003.6% | -544.3% | -488.7% | -298.2% | -385.9% | -182.6% | -171.1% | -200.6% | -148.9% | -112.2% | -85.4% | -108.8% | -100.7% | -112.2% | -122.2% | -153.6% | -61.8% | -54.0% | -86.0% | 20.1% | -31.3% | -12.9% | -1.7% | -21.7% | -32.7% | -7.0% | -4.6% | 19.1% | 14.7% | 19.0% | 13.8% | 16.6% | |
| -16.1% | -29.9% | -11.2% | -16.2% | -19.3% | -21.0% | -0.3% | 0.3% | 21.5% | 1.7% | 2.1% | 2.1% | -0.6% | -0.6% | 0.6% | 1.3% | 0.7% | 0.0% | 0.6% | 0.6% | 0.1% | -0.7% | 0.5% | 1.2% | 0.0% | 0.1% | 0.5% | 0.6% | 0.4% | 0.0% | 0.5% | 0.9% | 0.6% | -18.6% | 2.7% | 4.0% | -1.0% | -2.3% | -1.3% | 1.0% | -0.8% | |
| -762.4% | -647.0% | -565.9% | -743.3% | -719.1% | -375.0% | -644.8% | -546.9% | -11,855.1% | -1,005.3% | -546.4% | -490.9% | -297.6% | -385.3% | -183.2% | -172.4% | -201.3% | -148.9% | -112.8% | -85.9% | -109.0% | -100.0% | -112.7% | -123.4% | -153.6% | -61.9% | -54.5% | -86.6% | 19.7% | -31.4% | -13.3% | -2.6% | -22.3% | -14.1% | -9.7% | -8.6% | 20.1% | 17.0% | 17.6% | 12.7% | 16.8% | |
| -755.8% | -644.1% | -545.9% | -736.9% | -714.9% | -378.6% | -658.6% | -635.7% | -12,303.4% | -1,047.7% | -524.7% | -466.9% | -279.2% | -395.2% | -174.9% | -137.0% | -171.0% | -125.1% | -86.8% | -64.9% | -81.1% | -82.0% | -87.9% | -98.7% | -134.0% | -48.6% | -40.5% | -72.5% | 26.0% | -21.1% | -3.0% | 5.6% | -12.0% | -23.8% | 1.9% | 2.4% | 23.8% | 27.7% | 26.1% | 19.0% | 24.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.